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Abstract
Disease module is a group of molecular components that interact intensively in the disease specific biological network.
Since the connectivity and activity of disease modules may shed light on the molecular mechanisms of pathogenesis and
disease progression, their identification becomes one of the most important challenges in network medicine, an emerging
paradigm to study complex human disease. This paper proposes a novel algorithm, DiME (Disease Module Extraction), to
identify putative disease modules from biological networks. We have developed novel heuristics to optimise Community
Extraction, a module criterion originally proposed for social network analysis, to extract topological core modules from
biological networks as putative disease modules. In addition, we have incorporated a statistical significance measure, B-
score, to evaluate the quality of extracted modules. As an application to complex diseases, we have employed DiME to
investigate the molecular mechanisms that underpin the progression of glioma, the most common type of brain tumour.
We have built low (grade II) - and high (GBM) - grade glioma co-expression networks from three independent datasets and
then applied DiME to extract potential disease modules from both networks for comparison. Examination of the
interconnectivity of the identified modules have revealed changes in topology and module activity (expression) between
low- and high- grade tumours, which are characteristic of the major shifts in the constitution and physiology of tumour cells
during glioma progression. Our results suggest that transcription factors E2F4, AR and ETS1 are potential key regulators in
tumour progression. Our DiME compiled software, R/C++ source code, sample data and a tutorial are available at http://
www.cs.bham.ac.uk/~~ szh/DiME.
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Introduction
With the increasing availability of high-throughput, genome-
wide assay data and high-performance computational resources,
network biology (systematically reviewed by Baraba´si in [1]),
which addresses the intrinsic structure and organisation of
networks of pairwise biological interactions, has rapidly evolved
as a promising research area. Viewing the functional machinery of
the cell as a complex network of physical and logical interactions
rather than a simple assembly of individual functional components
has contributed unprecedented insight into the cell’s wiring
scheme.
The implications of methodology in network biology have been
taken a step further by network medicine which focuses on the
application to the understanding of complex disease pathophys-
iology [2]. The fundamental hypothesis is that the impact of
genetic and environmental disturbance upon disease phenotype is
likely to be asserted through coordinated activity of a group of
genes and their products which interact intensively, termed as
disease modules [2]. It has been argued that there is a significant
overlap among the topological module (e.g., highly interlinked
local region in the network), the functional module (e.g., a group of
molecular components responsible for a particular cellular
process), and the disease module consisting of disease-associated
genes. A primary objective in network medicine, therefore, is to
integrate the topological modules of biological networks and
functional annotation to identify disease modules that contain both
known and unknown disease genes and potential therapeutic
targets.
To identify disease modules with high confidence, the first and
most important step is the identification of significant and robust
topological modules in a network constructed from patient data
(e.g., gene co-expression network built from tumour microarray
data). Several module identification algorithms was previously
applied. One of the most popular algorithms is community
detection algorithm that maximises a modularity measure brought
forth by Newman (2006) [3]. Though it is capable of yielding
biological insight in several case studies (e.g. [4][5][6]), a major
drawback of the community detection algorithm is the resolution
limit problem [7][8] which results in huge modules with large
numbers of genes (e.g., in [5]). Such problem is serious in disease
module identification since it will inevitably introduce a lot of false
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disease genes (hence low specificity) and consequently adds
difficulties to validation and interpretation.
Another popular algorithm is Molecular Complex Detection
(MCODE) [9], which only identifies the nodes that actually belong
to a module. It was originally developed to discover protein
complexes in PPI networks but was extended to analyses of other
network types (e.g., [10]). The key idea of the MCODE algorithm
is to weight each node in the network with the minimum degree of
the most densely connected set of nodes in its neighbourhood
multiplied by the local density of that set, and recursively include
neighbouring nodes into a module according to a user-tunable
weight threshold starting from the highest weighting node.
MCODE in general generates smaller and denser modules than
the community detection algorithm does, but has the drawback
that it only considers local connectivity, i.e., the links inside a
module but ignores the links outside, which might generate biased
results towards disease modules that contain genes or proteins with
lots of interacting partners [11].
The community extraction (CE) algorithm is a novel commu-
nity structure identification algorithm originally proposed for
social network analysis [12]. This algorithm extracts the tightest
module at a time, regardless of whether the rest of the network
contains other modules. The algorithm is based on a novel module
criterion, called community extraction (CE) criterion, which
defines core modules in a network to be groups of nodes that
are as densely connected as possible within the group while as
loosely connected as possible to the rest of the network. This
module criterion is very attractive for disease module identification
because, unlike community detection, it will not result in huge
modules. Moreover, in contrast to MCODE, it takes into
consideration both the local connectivity of the module and its
relationship to the global topology of the entire network. However,
we found that in the original CE algorithm, the tabu search
algorithm [13,14], which is used for optimising the CE criterion, is
not scalable to handle medium and large networks, hampering its
application to disease module identification from biological
networks which commonly consist of thousands of nodes.
In this paper, we propose a novel Disease Module Extraction
(DiME) algorithm based on the CE criterion. Previously, we
proposed a evolutionary community extraction algorithm and
applied it to medium scale low and high grade glioma protein-
protein interaction networks [15]. In order to handle large-scale
biological networks, our DiME algorithm introduces a novel
search heuristics using a simple local moving algorithm and a
sample-and-seed step to prioritize candidate modules. Our
algorithm has the advantage of good scalability (quadratic in time
with respect to the network size), better accuracy and robustness
than existing methods, and having few parameters to tune. In
addition, we incorporated a statistical significance measure - the B-
score as defined by Lancichinetti et al. [16,17] - into the module
extraction workflow to assess the quality of extracted modules
without having to simulate large numbers of random networks for
p-value calculation.
After identification of topologically and statistically significant
modules, it would then be relatively straightforward to overlay
biological annotations from multiple sources, such as Gene
Ontology, transcription factor binding databases (e.g., the HTRI
database) and literature reported disease genes (e.g., from the
GeneCards catalogue) onto the modules to reveal key regulatory
processes in disease and prioritize possible disease modules.
As a case study we have applied DiME to gliomas (glial tumours
of the central nervous system). A large percentage (60%) of low
grade (grade II) glioma patients have relatively long survival length
of 5 years [18]. However, some patients may progress to more
aggressive high grade (grade IV or GBM) glioma, termed
Glioblastoma multiforme (GBM), which has a short survival
length of approximately 15 months [19]. Although GBM has been
intensively studied, the molecular mechanisms that underpin the
progression from low to high grades gliomas still remain unclear.
We have applied our DiME algorithm to two co-expression
networks constructed from high- and low-grade glioma patient
data to extract statistically significant modules. We then have
compared the topology and activity (expression) of the disease
modules, their functional annotations and regulatory mechanisms,
to gain insights into molecular mechanisms in the acquisition of
more aggressive malignancy during glioma progression. We have
identified several statistically significant modules which are
reproducible across three different datasets as potential disease
modules. We then discovered that the dynamic activity, e.g., gene
expression levels of these disease modules correlated with glioma
progression. Finally from these disease modules we identify their
upstream transcription factors E2F4, AR and ETS1 as potential
key regulators in tumour progression.
Methods
The DiME framework
A general work flow of the DiME framework for disease module
identification and analysis is given in Figure 1. Note that our
framework is readily adaptable to other types of study. For
example, the construction of co-expression networks may be
replaced by PPI networks to examine protein complexes or
signaling modules, and the procedures downstream of the
statistical significance evaluation step may also be varied according
to specific aims of research, e.g. validation of disease modules via
prediction of patient recovery/survival instead of correlating with
tumour grade in our case study. In the following sub-sections, we
provide details for the core steps of the DiME work flow - network
construction, module extraction algorithm and evaluation of
statistical significance.
The DiME algorithm
Our DiME algorithm, as summarised as pseudo-code in Table 1,
aims at maximizing the following objective function for commu-
nity (termed as ‘‘module’’ throughout this paper) extraction
defined in [12]:
~WS~DSD:DScD:
OS
DSD2
{
BS
DSD:DScD
 
, ð1Þ
where S and Sc denote a module and its background network,
respectively. OS~
P
i,j[S Aij , BS~
P
i[S,j[Sc Aij and Aij is the
adjacency matrix. D:D denotes cardinality. Intuitively the criterion
seeks to maximise the density of connections within a module and
minimise that with the rest of the network.
Maximizing the above objective function is essentially a
combinatorial optimization problem, where each solution i can
be represented as a binary vector of 0 s and 1 s that denote the
module membership status of each node:
xi~ xi1,x
i
2,:::,x
i
N
  ð2Þ
where
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xij~
1 if j th node is in module
0 otherwise

and N equals the total number of nodes in the network.
Finding the exact optimal solution for the problem takes
exponential time. Therefore in the original publication [12], a
generic metaheuristic algorithm, e.g., tabu search was used to solve
the problem. Similarly, other metaheuristic algorithms such as
evolutionary computation can be used [15]. However, from our
experience, these generic metaheuristic algorithms suffer from
scalability issues, e.g., when network size grows larger the time
required for extracting a module increases disproportionately and
quality of the extracted modules deteriorate significantly. This
Figure 1. General work flow for the DiME framework.
doi:10.1371/journal.pone.0086693.g001
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scalability issue greatly hinders the application of module
extraction to biological network analysis where most of the
networks consist of thousands of nodes.
In this paper, we propose a simple greedy local search algorithm
that efficiently handles large networks. At each iteration, the
algorithm visits all nodes in a sequential order. For each node, the
algorithm performs the best move, e.g, flip the membership status
of the node if it increases ~W . The algorithm iterates until no ~W -
increasing move is found for any node. In order to speed up the
algorithm, we only calculate the changes in the value of ~W :
D ~Wk~
OS:
N
DSD DSD{1ð Þ{2
N
DSD{1
P
j[S Akj xjz
P
j[S Akj if k[S
{OS:
N
DSD DSDz1ð Þz2
N
DSDz1
P
j[S Akj xj{
P
j[S Akj if k[Sc
(
where OS~
P
i,j[S Aijxixj . The detailed derivation of
~W is
provided in Section S3 in File S1. The local moving algorithm is
summarised as pseudo-code in Table 2.
However, our greedy local search algorithm will be trapped by
local minima and the initial starting point is crucial to its
performance. We propose a sample-and-seed approach to guide
the greedy local search that both speeds up the search process and
obtains better optima than the commonly used methods (data not
shown). As shown in Table 3 and Table 4, the approach consists of
two distinct stages of optimization: a sampling stage and a seeding
stage. In the sampling stage, a small number of solutions are
optimized using our local greedy search algorithm mentioned
above, resulting in a set of locally optimal solutions. Note that at
this stage no prior information about the size distribution of
modules in the network is available, thus a gradient-like
probability for each node being ‘‘1’’ is used, i.e., probabilities
ranging from 0 to 0.5 are used evenly among the solutions. The
probability is capped at 0.5 as we assume that for large biological
networks it is unlikely that a meaningful module would cover more
than half of the entire network. The optimized solutions are then
passed to the second stage of the algorithm to estimate
probabilities for each node being the ‘‘seed’’ of a module, which
are then used to initialize a new set of solutions for optimization.
The estimation and seeding process used in our algorithm is
relatively simple and straightforward: since our DiME method
only extracts a single best module at a time, and by definition such
a module should be a connected subgraph of the entire graph, we
could for each extraction procedure view each node as a possible
‘‘seed’’ for the module to be extracted, which will progressively
include its surrounding nodes to form the module during
optimisation. The initial extraction with relatively few individuals
would, then, act as the seed prioritizer. The probability of each
node becoming the seed is naturally designed to be proportional to
the frequency it appears in the initial solutions (Pj denotes
probability of node j becoming the seed):
Pj~afj~
a
N
X
i
xij ð3Þ
Additionally, when viewed as a probability mass function (PMF)
where each node position corresponds to a certain (possibly zero)
probability of being the seed, the probabilities of the nodes being
the seed should also sum to one:
X
j
Pj~
a
N
X
j
X
i
xij~1, ð4Þ
which yields
Table 1. Algorithm 1. DiME algorithm. 
Require: N|N adjacency matrix A, number of initial solutions to be used (M)
repeat
Create M empty solutions (binary vectors) x1,x2,:::xM of length N
SAMPLING(x1,x2,:::xM ,A)
Create empty real-valued vector p of length N
SEEDING(x1,x2,:::xM ,p)
Create 10|M empty solutions x1,x2,:::x10M of length N
for i~1?10M do
for j~1?N do
if randNumvpj then
xij/1
else
xij/0
end if
end for
LOCALMOVING(xi ,A)
end for
Return solution with highest ~W
Delete current best solution (module) from network and update A
until highest ~W~0
doi:10.1371/journal.pone.0086693.t001
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a~
NP
i
P
j xij
ð5Þ
Plug a into equation 3, the above probabilities Pj could be
estimated by
Pj~
P
i xijP
i
P
j xij
: ð6Þ
These probabilities are then used to randomly seed a set of
solutions. For the ith node, a random number randNum is
generated and compared with pj , if randNumvpj , then xij is
seeded as 1, otherwise 0. Repeat this for all N nodes to obtain
solution x. We construct 10M solutions and optimise them using
local moving. After all 10M rounds of local moving, the best
solution that emerges will be returned.
To extract all possible modules from the network, a sequential
extraction procedure is used where each extracted module is
deleted from the network before extracting the next one, until no
more modules can be extracted from the network (i.e., best ~W
becomes 0). In all following analyses only modules with size larger
than 2 were considered valid.
Evaluation of the statistical significance of extracted
modules
To ensure that the modules extracted from the biological
networks are statistically significant, i.e. they are significantly
different from modules that arise from random networks of an
appropriate null model, we incorporated a B-score significance
measure as proposed in [16][17] as a quality control step for the
modules. The B-score measure assumes a null model where edges
within the module (community) of interest is held unchanged while
the remaining connections in the network are randomly shuffled.
Then the B-score is calculated based on the null module to
Table 2. Algorithm 2. Local moving function.
function LOCALMOVING(binary vector x, adjacency matrix A, problem size N)
~W/ ~W (x)
incr/FALSE
repeat
for j~1?N do
if D ~Ww0 then
xj/1{xj
incr/TRUE
end if
end for
until incr~~FALSE
end function
doi:10.1371/journal.pone.0086693.t002
Table 3. Algorithm 3. DiME sampling function.
function SAMPLING(binary vectors x1,x2,:::xM of length N , network adjacency matrix A)
for i~1?M do
for j~1?N do
if randNumv0:5| i
M
then
xij/1
else
xij/0
end if
end for
end for
for i~1?M do
localMoving(xi ,A)
end for
end function
doi:10.1371/journal.pone.0086693.t003
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quantify how often we should expect to see the module ‘‘by
chance’’. The B-scoring measure has a major advantage of
avoiding large amounts of resampling cycles for simulating null
model results. In our later experiments, we also showed that the B-
scoring measure worked well with our DiME algorithm to detect
statistically significant modules.
For details of the B-score calculation, the reader is referred to
the original works [16][17]. In order to make this paper self-
contained, we provide the full procedure for B-score computation
in Section S1 in File S1. In this study all B-score calculations were
based upon default parameters in the original work with 20
independent runs for each module evaluation.
Data acquisition and preprocessing
Raw expression data of 97 WHO grade II glioma patient and
126 glioblastoma (GBM) samples was downloaded from the NCI
Rembrandt database [20]. The expression data was collected
using Affymetrix Human Genome U133 Plus 2.0 microarrays
(54,675 probe sets in total). Raw expression (.CEL files) was
preprocessed and normalized using standard Robust Multi-array
Average (RMA) [21] procedures in R and filtered for probe sets
with duplicate Entrez ID mappings, no Entrez IDs or low variance
in expression values (in this case lower 50% quantile of inter-
quartile ranges). The resulting expression matrix contained 9,971
genes.
Two independent sets of brain tumour data for validation: the
TCGA GBM dataset and grade II glioma expression dataset from
the Gene Expression Omnibus database (GSE30339) [22], each
consisting of 197 and 23 samples respectively (low-grade glioma
data sources are relatively scarce) - were downloaded from the
respectively online data repositories. The validation sets used the
Affymetrix HG-U133A arrays (22,277 probe sets in total), different
from the Rembrandt dataset. The downloaded datasets were
already preprocessed and normalized with standard RMA
[21]methods, and were subsequently filtered using R for non-
specific binding with the same method as described above for the
Rembrandt datasets. Preprocessing of the microarray data resulted
in a total of 6,247 genes.
Glioma co-expression network construction
For samples in each tumour grade, pair-wise Pearson’s
correlation coefficient (PCC) was calculated for each gene pair
to generate the correlation matrix of all genes. In order to guard
against possible outliers, a jackknife [23][24] approach was used to
estimate the true gene expression correlation coefficients. The raw
PCC values, r, were first converted to z values using Fisher
transformation [23]:
z~
1
2
ln(
1zr
1{r
) ð7Þ
The (z-transformed) jackknife correlation value for any given
gene pair (gi,gj) (i=j), ~zgi ,gj , is calculated as follows:
~zgi ,gj~Nzgi ,gj{
N{1
N
XN
k~1
zJ(k)gi ,gj
ð8Þ
where N is sample size and zJ(k)gi ,gj
is z-transformed PCC between
genes i and j calculated with the kth sample excluded.
To construct a co-expression network, similar to the construc-
tion method used in [25], we ranked all gene pairs according to
their absolute values of the jackknife correlation values Dzgi ,gj D. We
then selected the a certain percentage of the top ranking gene pairs
as significant co-expressions, which will be connected as a co-
expression network. This percentage, called network construction
threshold in our paper, will affect the edge noise level of the
resulting network. For example, a stringent threshold will miss
large numbers of true edges while a larger threshold will introduce
many false-positive edges. For our glioma co-expression network
analysis, we set the network construction threshold to 0.1%. In the
Results section, we also present data regarding how different
network construction threshold values, therefore different noise
levels, affect module extraction results of the DiME algorithm.
Our main analyses will be focused on the Rembrandt grade II
glioma and GBM datasets described in Data Acquisition and
Preprocessing, and datasets from other sources will be used for
result validation. The resulting networks for the Rembrandt
datasets contained 2,739 (GBM) and 3,888 (grade II glioma) nodes
(genes) respectively. The networks have 49,705 edges for both
GBM and grade II glioma networks. The resulting networks both
followed good power-law degree distribution, with power-law fit
correlation of r2~0:845 (GBM) and r2~0:903 (grade II glioma)
respectively.
Results
The DiME algorithm has better accuracy and scalability
than the original CE algorithm
Since biological benchmark networks are scarce, we chose four
social networks, which have been widely used as benchmarks in
many previous studies, to evaluate the accuracy and scalability of
our DiME algorithm in comparison with the original CE
algorithm. In addition, these four benchmark networks also
covered a wide range of size and complexity and are thus ideal
Table 4. Algorithm 4. DiME seeding function.
function SEEDING(real vector p~(p1,p2,:::,pN ), solutions from sampling x
1,x2,:::xM )
for j~1?N do
pj/
PM
i~1 xijPM
i~1
PN
j~1 xij
end for
end function
doi:10.1371/journal.pone.0086693.t004
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for evaluating the scalability of DiME. These benchmark networks
include: 1) a university e-mail network [26], referred to as the
Email network; 2) the Erdo¨s collaboration network among
mathematicans [27], referred to as the Erdo¨s network; 3) a
network of users of the pretty good privacy (PGP) algorithm for
secure information transactions [28], referred to as the PGP
network; 4) the relationships between authors that shared a paper
in condensed matter physics [29], referred to as the Cond-mat
network. The basic characteristics of the network are listed in
Table 5.
We ran the DiME algorithm to extract the tightest module (i.e.,
module with highest ~W in the network) in each network and
repeated the extraction for 50 times to calculate the mean and
standard deviation of ~W and computation time. We compared our
DiME algorithm with the original CE method which is based on
the tabu search algorithm. In our experiments, we used a tabu list
size of 10, and for each independent run the algorithm stopped
when the highest ~W ever achieved did not increase in 300
consecutive iterations. The choice of tabu list size, ranging from 2
to 100, did not affect the general output ( ~W , data not shown), and
a choice of 300 iterations in the stopping criterion is a compromise
between computational overhead and full convergence of the
algorithm. All these experiments were performed using single CPU
threads.
The statistics for ~W and computation time were shown in
Tables 6 and 7, respectively. Note that no data was shown for the
Cond-mat network using original CE algorithm as it took several
hours even for a single run which made multiple runs infeasible.
It can be seen from Table 6 that in general our DiME algorithm
outperforms the original CE algorithm in terms of accuracy as it is
capable of locating better maxima of ~W for the Email and PGP
networks with relatively low variation in the 50 trial runs. DiME is
also more scalable than the original CE algorithm as it consumes
significantly less average computation time with much smaller
standard deviations, as shown in Table 7.
Parameter setting of the B-score cutoff
One parameter that needs to be tuned in DiME is the statistical
significance (B-score) cutoff for extracted modules. As the B-score
cutoff becomes smaller, e.g., more stringent, more modules and
thus more genes including disease genes would be discarded,
decreasing the sensitivity of DiME. Vice versa, when the B-score
cutoff becomes larger, large number of non-disease genes will be
included which reduces DiME’s specificity.
In order to balance the specificity and sensitivity of DiME, we
carried out experiments to find the optimal value of B-score cutoff.
Since the B-score is based on null distribution probabilities and
may thus be viewed as the widely used statistical p-values, here we
evaluated the loss of genes under three most commonly used levels
of statistical significance cutoff - 0:05,0:001 and 1|10{5. The
results for all datasets used in this paper (see Data Acquisition and
Preprocessing in Methods for dataset specifics) are shown in
Table 8.
Table 8 shows that in general 50%–70% of the genes identified
by the DiME algorithm belong to modules with B-score statistical
significance level of 0:05, 0:001 and 1|10{5. The percentage of
retained genes experienced a large decrease at a B-score cutoff of
0:001, but dropped more smoothly at a further increase in the
stringency of cutoff. Observe that the grade II glioma datasets
show a larger loss of genes than the GBM datasets at the same
cutoff, probably due to the relatively scarcer low-grade glioma
samples and possibly higher tumour heterogeneity in the sample
cohort. It seems that 0:001 is a reasonable value for the B-score
threshold where relative loss of genes stops increasing dramatical-
ly. We used this 0:001 as our default value throughout our
experiments.
Statistical significance measure B-score correlates with
module extraction criterion ~W
In order to investigate the relationship between Statistical
significance measure B-score and module extraction criterion ~W ,
we applied our DiME algorithm to extract all modules from the
Rembrandt grade II glioma and GBM networks. We excluded
modules identified by DiME with size smaller than 2 genes. We
calculated the Pearson’s correlation between B-score and ~W . As
shown in Figure 2, the B-score of statistically significant (B-score
v0:05) modules extracted from both the glioma networks is well
correlated with the value for the CE criterion, ~W (Pearson’s
correlation test p-values smaller than 0:0001), indicating that the
CE criterion is likely to be built upon a null model which fits well
with that assumed by the B-score measure.
DiME identifies more significant modules than the
community detection algorithm
Using Rembrandt glioma networks, we carried out experiments
to compare the performance of DiME with the community
detection algorithm [30]. It is worth mentioning that although the
community detection algorithm essentially partitions the network
into modules, which is very different from our DiME algorithm
and therefore difficult to compare with, it is still interesting to
investigate which algorithm is better at identifying biological
relevant disease modules.
We executed the community detection algorithm on the
Rembrandt networks to partitioned the two networks into 131
and 105 modules, respectively. However, we found that the largest
module identified by the community detection algorithm consist-
ing of 1,372 genes out of a total of 3,888, and is statistically non-
significant under the B-score scheme (B~0:17). A careful
inspection of this large module shows that three of the statistically
significant (Bv0:001) modules extracted by DiME, with sizes of
212, 39 and 42 genes respectively, are contained or almost
contained within it (i.e., over 90% overlap with the large module).
It also has significant overlaps with several other non-significant
DiME modules. Such an observation suggests that community
detection is not appropriate for disease module identification in
large biological networks, since it generates huge modules with
large numbers of genes of different functions, which adds
difficulties to validation and interpretation. Based on the results,
we exclude community detection for comparison with DiME in
the subsequent experiments.
DiME is more robust for identifying significant modules
from noisy co-expression networks than MCODE
As discussed in the network construction section, the network
construction threshold for selecting significant co-expressions as
Table 5. Characteristics of the benchmark networks.
Network Name
Algorithm Email Erdo¨s PGP Cond-mat
No. of Nodes 1,133 6,927 10,678 27,519
No. of Edges 5,451 11,850 24,316 116,181
doi:10.1371/journal.pone.0086693.t005
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edges significantly affects the edge noise level of the resulting
network. In this sense is the DiME algorithm able to robustly
capture the most essential (‘‘core’’) topological components of the
network against different levels of edge noise? In other words, will
the modules extracted by DiME differ significantly when the
network noise level is altered?
In order to evaluate the robustness of DiME, we define a
conservation score, which essentially quantifies the similarity
between the modules extracted from a noisy network and those
extracted from a reference network, which can be viewed as a
ground-true network without any edge noise. We chose the two
Rembrandt networks of grade II glioma and GBM with a network
construction threshold of 0.1% as the reference networks for
comparison since they are the networks that were used in our
further analyses. The details of the calculation of the conservation
score is in Section S2 in File S1. We then constructed noisy
networks with different levels of edge noise by changing the
network construction thresholds of the reference networks to
0.5%, 0.2% and 0.05%. The DiME algorithm was then applied to
each of these networks to identify all modules for the calculation of
the conservation score. Box plots of the distribution of scores
across modules in a network were plotted. We also compared the
popular MCODE algorithm [9] with DiME using the same
experiments.
As shown in Figure 3, the conservation scores of DiME modules
were significantly better (Student’s t-tests pv0:001) than those of
MCODE modules across networks constructed with the same set
of genes but different edge noise levels. Such robustness is further
strengthened by the fact that under all B-score cutoffs the DiME
algorithm extracts more nodes in total than does MCODE, and
that loss of nodes in DiME modules was not very dramatic even
under very stringent B-score cutoffs (See Table S1 in File S1).
Module extracted by DiME from Rembrandt Grades II and
GBM networks are biologically relevant to glioma
progression
We applied the DiME algorithm with a B-score cutoff of 0:001
to the two Rembrandt glioma datasets, and visualised the resulting
modules and their interconnectivity in Figures 4 and 5. Each
module is annotated with a specific function summarised from its
enriched Gene Ontology terms (false discovery rate v0:05 in
hypergeometric tests). Edge widths are designed to be proportional
to the number of connections (co-expression pairs) between two
modules, in order to illustrate strength of coordination between
functional components in the disease network. Node color
represents fold change of average expression level of all genes in
one module compared with normal patient samples.
The grade II glioma module network (Figure 4) demonstrates a
significant shift in the tumour phenotype compared with normal
samples. As would be expected, there appears to be a marked
down-regulation of normal neuronal function (i.e. synapse
transmission-related processes), and a significant increase in cell
cycle-associated processes. It is of interest to note that the modules
associated with immune response are slightly, but significantly
increased in grade II tumours.
As shown in Figure 5, progression to grade IV (GBM) is marked
by a significant shift in network topology despite the general
conservation of module functional annotation: inter-module
connectivity was significantly altered in the GBM tumour network
compared with that of grade II gliomas, with strengthened co-
expression between cell cycle-related processes and ECM
reorganisation and modules associated with differentiation status,
such as synaptic transmission and CNS development. In addition,
there was a breakdown in the co-expression of immune processes
and the above mentioned modules. However, GBM tumours
appear to have altered levels of transcripts involved in extracellular
matrix (ECM) reorganisation and angiogenesis - markers of a
more aggressive phenotype.
Modules extracted by DiME from Rembrandt grade II and
GBM networks are reproducible in independent datasets
To verify the reproducibility of the disease modules from the
Rembrandt networks, we applied the DiME work flow to two
independent sets of brain tumour data: a GBM dataset from the
TCGA database, and a WHO grade II glioma expression datasets
from the GEO database published by Turcan et al. [22], which
used a different microarray chip from that used by the Rembrandt
dataset (see Data Acquisition and Preprocessing in Methods for
details). The aim of this experiment is to see if DiME can extract
disease modules that reproducible in independent datasets. The
Table 6. ~W scores of the first module of each benchmark network.
Network Name
Algorithm Email Erdo¨s PGP Cond-mat
DiME 14420.04622.76 103544.862.32 401530.966274.66 303292560
Original CE 12967.58614.18 103587.5679.22 38567563681.49 -
The results in bold font indicate the they are statistically significant (Student’s t-tests pv0:05).
doi:10.1371/journal.pone.0086693.t006
Table 7. Computation time (second) for extracting the first module in each benchmark network.
Network Name
Algorithm Email Erdo¨s PGP Cond-mat
DiME 0.91560.104 30.83762.419 54.43662.705 350.920623.567
Original CE 1.21960.246 162.0236641.856 463.9166364.553 -
The results in bold font indicate the they are statistically significant (Student’s t-tests pv0:05).
doi:10.1371/journal.pone.0086693.t007
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same DiME work flow, i.e., disease co-expression network
construction, module extraction and evaluation of statistical
significance were performed using exactly the same methods and
parameters as those for the Rembrandt dataset. We also employed
MCODE for comparison. The same experiments and the same
work flow except evaluation of statistical significance, i.e., B-score
thresholding (see discussion) were applied.
Network construction resulted in a network with 3,635 nodes
and 19,509 edges for the GEO grade II glioma expression data,
and one with 1,787 nodes and 19,509 edges for the TCGA GBM
data. The GEO grade II glioma data co-expression network had
1,617 nodes in common with the Rembrandt network (Jaccard
index 0.2737), while the TCGA GBM network had only 717
nodes in common with the Rembrandt counterpart (Jaccard index
0.1882). We show that even in this situation where the two sets of
glioma disease networks significantly differ from each other in
gene ensemble, our DiME algorithm is still capable of reproducing
modules with fairly similar composition.
Because classical methods for comparing graph clusterings, e.g.,
the adjusted Rand index or normalized mutual information [31],
are designed for comparing partitioning of the same network, they
cannot be used to evaluate the similarity between extracted
modules of the Rembrandt dataset and those of the validation
datasets. Here we score the reproducibility of each module from
the Rembrandt networks (grade II glioma and GBM) using the
following steps:
1. For each tumour grade, project all modules from both the
Rembrandt and the validation (TCGA or GEO) network onto
the intersection of all genes in the two networks, resulting 2 sets
of projected modules. (Projection is calculated as intersection.)
2. For each projected module with size larger than 5 from the
Rembrandt network, calculate its maximum possible Jaccard
index with the projected modules (corresponding to a best-
matching pair of modules) from the corresponding validation
network and return the Jaccard index as its reproducibility
score.
Note that we chose a module size threshold of 5 here to guard
against random effects brought about by small modules. Such a
threshold did not qualitatively affect comparison with the
performance of MCODE over a reasonable range of 2–10 (data
not shown).
The results are shown as box plots of Jaccard index distributions
in Figure 6. Average Jaccard indices of 0.28 and 0.51 were
observed for the grade II and GBM datasets respectively, showing
a high level of module reproducibility for both tumour grades
considering the remarkable differences in the microarrays.
Inspection of Gene Ontology enrichment of modules in the
independent datasets also showed that they are functionally similar
to the matched modules in the Rembrandt counterpart (data not
shown). It may be seen from the GBM data box plots that under
stringent B-score cutoffs (Bv0:001) the upper quantiles of the
Jaccard index distribution show markedly increased average values
and decreased range of variation, compared with those of
MCODE modules. The average Jaccard index for all DiME
modules with Bv0:001 is also significantly higher than that of the
MCODE modules (Student’s t-test, pv0:05) in the GBM datasets,
Table 8. Relative loss of genes under different B-score cutoffs.
B-score Cutoff
Algorithm 0.05 0.001 1|10{5
Rembrandt Data (GBM) 32.97% (574/1741) 50.09% (872/1741) 54.68% (952/1741)
TCGA Data (GBM) 30.19% (358/1186) 42.50% (504/1186) 51.85% (615/1186)
Rembrandt Data (grade II Glioma) 47.27% (1230/2602) 62.95% (1638/2602) 68.14% (1773/2602)
GEO Data (grade II Glioma) 42.46% (1106/2605) 66.64% (1736/2605) 71.48% (1862/2605)
doi:10.1371/journal.pone.0086693.t008
Figure 2. Correlation of ~W scores with B-scores. All modules with size larger than 2 and B-scorev0:05 are included. A few modules whose B-
score is 0 (indicating scores exceeding the lower limit of detection in the B-score algorithm) were excluded. Fitted lines of log10( ~W ) versus{log10(B)
are shown. The fitted Pearson’s correlation r2 values are 0.57 (grade II glioma, left panel) and 0.65 (GBM, right panel) respectively, with both
correlation p values smaller than 0.0001 in Pearson’s correlation tests.
doi:10.1371/journal.pone.0086693.g002
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and a similar trend, though not highly significant (Student’s t-test,
p~0:09), was observable for the grade II glioma datasets.
Statistical insignificance may be attributed to the fact that the
MCODE modules showed large variance in the Jaccard indices. It
is noteworthy that the low-grade glioma data generally displayed
considerably less reproducibility than that of the high-grade
counterpart. This might be due to the relatively smaller sample
size and possible heterogeneity in the samples (which might
indicate existence of molecular subtypes across the patient
cohorts).
Expression levels of common modules shared by Grade II
and IV gliomas are correlated with tumour grade
It is natural to expect that disease modules extracted from grade
II and GBM sample datasets might be used to distinguish samples
of different tumour grades. Such distinguishibility did not seem to
be readily achievable solely at the functional level: GO Biological
Process enrichment analysis of the two sets of modules obtained
from the two tumour grades showed that they are enriched with
highly similar functions, with the majority of modules in both
grades functionally annotated with 1) immune response, 2)
synaptic transmission, 3) cell cycle regulation, 4) nervous system
development and/or 5) cell migration/adhesion, though the GBM
modules seemed to have a larger portion annotated with immune
response and cell cycle-related functions. We hypothesize that a
combination of functional annotation and expression landscape of
the common modules, however, may shed light upon the shifts in
the major regulatory mechanisms responsible for tumour progres-
sion.
To test our hypothesis, we first matched functionally similar
modules extracted from the Rembrandt grade II and GBM
networks using a GO semantic similarity measure as used in [5].
Using this method, we obtained a pair-wise similarity matrix by
calculating the GO semantic similarity measure between all pairs
of modules with one module from the Rembrandt grade II glioma
network and the other from the Rembrandt GBM network. Since
the number of modules extracted from the GBM network and of
those from the grade II glioma network are similar, best-matching
module pairs may be easily found by the Hungarian algorithm for
assignment problems [32] [33]. The above process resulted in 41
best-matching pairs (one-to-one mapping) of modules which were
then intersected to yield 12 common modules shared by both
tumour grades in the Rembrandt networks. We discard the
modules with less than 5 genes to guard against possible artifacts of
noise in data acquisition and/or network construction. The 12
modules were then projected onto the gene universe of the
independent GEO grade II glioma and TCGA GBM networks to
identify common modules that are conserved across two micro-
array types. We also excluded modules with less than 5 genes. The
final set of common modules is comprised of 9 modules and 208
genes.
Two-tailed Jonckheere-Terpstra test was then performed to
examine whether tumour grade was correlated with the expression
signature of the 9 conserved modules. The expression signature of
each common module was calculated as the average expression of
all genes in the module. The test discovered 7 out of the 9
common modules (183 genes in total) whose expression signatures
were significantly correlated with tumour grade (p value v10{5
after adjusting for FDR control).
We carried out GO Biological Process enrichment analysis on
the 7 common modules. As tabulated in Table 9, the 7 common
modules are all significantly enriched with at least one GO BP
term after Benjamini-Hochberg adjustment for false discovery rate
(FDR v0:05). It is also interesting to see from the table that the
functional annotations of these modules covered most of the
summarised functions in the connected components of module
inter-connectivity networks shown in Figure 4.
Figure 7 shows a heat map of the expression level of individual
genes in the 7 modules grouped by modules (rows) and samples by
tumour grade (columns). The clear differential expression patterns
of genes belonging to the same module across grades are easily
observable in Figure 7. For example, activity of modules 1 and 7,
Figure 3. DiME is robust to edge noise in co-epxression networks. Shown in the plots are results for the grade II glioma networks (left panel)
and GBM networks (right panel). The horizontal axes display the technique used, and vertical axes show average conservation scores. Only modules
with size larger than 5 are taken into consideration. Asterisks denote statistical significance in Student’s t-tests when comparing means with MCODE
modules: ‘‘***’’ - pv0:001.
doi:10.1371/journal.pone.0086693.g003
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corresponding to the regulation of immune response, increased
with malignant progression - i.e. grade II to GBM. Taking into
account that the expression arrays were performed on samples of
the total tumour mass (not isolated glial cells), and the nature of the
transcripts represented by the immune-associated modules, this
may be a significant observation. We hypothesize that the
significant loss of co-expression observed between the modules
associated with cell cycle and glial differentiation and those
involved in immune function is indicative of the infiltration of
immune cells into the tumour mass in GBM samples. Indeed, this
is in agreement with literature reports that have shown an increase
in T cell infiltration into GBMs which is around 5 times more than
that observed in grade II gliomas [34].
Regulatory mechanisms underlying the common
modules shared by grades II and IV
We also extracted the transcription factors that bind to the genes
of each common modules from the Human Transcriptional
Regulation Interactions database developed by Bovolenta et al.
(2012) [35]. We summarise the results in Table 9. An intriguing
observation is that the 7 commonmodules showed high similarity in
their transcriptional regulators, as seen from the transcription
factors that bind to genes in each module. All 7 modules are
regulated by ETS1, which is involved in the control of stem cell
development and often in tumorigenesis [36–38]. E2F4, a
transcription factor that binds to and inhibits several tumour
suppressor proteins, as well as induces DNA synthesis required for
cell proliferation, is also shared by 5 modules. Another important
cancer-associated transcription factor that is shared among the
modules is AR, a steroid hormone receptor that regulates
Figure 4. Visualisation of grade II glioma modules with B-score less than 0:001 and their inter-module connectivity. Nodes represent
extracted modules, node size represents module size and node color represents (log-transformed) fold-change in average module gene expression
level compared with normal patient samples (Red - increase in average expression, green - decrease in average expression, lavender - no change in
average expression). Edge widths are proportional to connectivity (i.e., number of co-expression gene pairs) between module pairs.
doi:10.1371/journal.pone.0086693.g004
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downstream processes such as proliferation and differentiation and
whose mutation has been shown to play important parts in cancer
[39–41]. The transcription factors E2F4, ESR1, ETS1 andMYC are
all downstream targets of the well-established tumour supressor
gene TP53 that is responsible for multiple alterations in the gene
regulatory network in gliomablastoma [42–44]. These results
suggest that the common modules identified through our method
are likely to be downstream mediators of the effects of alterations to
master regulators in glioblastoma-associated pathways.
DiME Identifies Unique Biologically Relevant Modules
Not Discovered by Other Methods
In order to investigate whether DiME can discover modules
that cannot be identified by other algorithms, we compared all B-
score significant (v0:001) DiME modules to those identified by
MCODE and the original CE algorithm. We defined a module to
be missing if it has no corresponding modules showing an overlap
of larger than 20% of the smaller module in comparison.
Our results showed that the original Tabu-search based CE
algorithm, under the same ~W module criterion, failed to identify
several both statistically significant and biologically meaningful
coexpression modules in grade II glioma and GBM. Besides, the
results were highly unstable across independent runs. Even when
we looked at the best results (containing 7 and 6 modules with B-
scorev0:001 for grade II glioma and GBM respectively) we have
so far obtained, the original CE algorithm still missed several of the
statistically significant DiME modules shown in Figures 4 and 5,
Figure 5. Visualisation of GBM modules with B-score less than 0:001 and their inter-module connectivity. Nodes represent extracted
modules, node size represents module size and node color represents (log-transformed) fold-change in average module gene expression level
compared with normal patient samples (Red - increase in average expression, green - decrease in average expression, lavender - no change in
average expression). Edge widths are proportional to connectivity (i.e., number of co-expression gene pairs) between module pairs.
doi:10.1371/journal.pone.0086693.g005
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such as the large ‘‘immune response’’ module in grade II glioma
and the ‘‘myelination and CNS development’’ module in GBM.
There is one module from each of the two grades that was
identified by DiME method but missed by the MCODE method.
As they were also missed by the original CE method, we view these
modules as uniquely identified by DiME, and employ previously
reported evidence to demonstrate their pathophysiological rele-
vance. Both modules contain more than 10 genes and are thus
non-trivial.
In the unique module identified by DiME from the grade II
glioma network (corresponding to ‘‘mesenchyme morphogenesis
and cell division/differentiation’’ module in Figure 4), we highlight
Figure 6. Comparison of module reproducibility among different algorithms. Shown are box plots of average reproducibility (Jaccard
index) for each technique used. Asterisks denote statistical significance in Student’s t-tests when comparing means with MCODE modules: ‘‘*’’ -
pv0:05.
doi:10.1371/journal.pone.0086693.g006
Table 9. Summary of functional annotation and location information of the conserved common modules.
Module
Number Top 3 GO BP Terms
Chromosome
Locations
Transcription
Factors
1 immune response (p~2:8|10{20)
immune system process (p~3:2|10{20)
regulation of immune system process (p~1:1|10{16)
1, 2, 3, 4, 5, 6, 7, 8,
9, 10, 11, 12, 14, 16,
17, 19, 20, 21, 22, X
AR, E2F4, EGR1, ETS1,
GATA2, GATA3, YBX1
2 synaptic transmission (p~9:6|10{20)
multicellular organismal signaling (p~1:9|10{19)
cell-cell signaling (p~7:4|10{19)
1, 2, 3, 4, 5, 6, 7, 8,
9, 10, 11, 12, 13, 15,
16, 17, 19, 20, 22, X
AR, E2F4, ESR1, ETS1,
FOXP3, GATA1, GATA2,
HIF1A, MYC, YBX1
3 nervous system development (p~2:3|10{3)
myelination (p~3:7|10{3)
ensheathment of neurons (p~3:7|10{3)
1, 2, 3, 4, 6, 7, 8, 9,
11, 12, 15, 16, 17,
19, X
AR, ESR1, ETS1, GATA2,
PRDM14, TFAP2C, YBX1
4 ribonucleoside triphosphate catabolic process (p~1:2|10{2)
purine ribonucleoside triphosphate catabolic process (p~1:2|10{2)
positive regulation of growth (p~1:2|10{2)
3, 6, 7, 8, 12, 14, 17,
X
AR, ESR1, ETS1, HIF1A
5 antigen processing and presentation of exogenous peptide antigen via MHC class I,
TAP-dependent (p~3:5|10{12)
antigen processing and presentation of exogenous peptide antigen via MHC class I
(p~3:5|10{12)
antigen processing and presentation of peptide antigen via MHC class I (p~9:4|10{12)
6 E2F4, ETS1
6 M phase (p~2:0|10{8)
cell cycle progress (p~2:4|10{8)
nuclear division (p~3:4|10{8)
1, 4, 8, 10, 15, 17,
20
AR, E2F4, ESR1, ETS1
7 type I interferon-mediated signaling pathway (p~2:5|10{9) cellular response to type
I interferon (p~2:5|10{9)
response to type I interferon (p~2:5|10{9)
1, 2, 12, 21 AR, E2F4, ETS1, GATA1
doi:10.1371/journal.pone.0086693.t009
DiME with Application to Glioma Progression
PLOS ONE | www.plosone.org 13 February 2014 | Volume 9 | Issue 2 | e86693
the genes ABCA5, RGN and MYC, all among the top degrees of
connectivity in the module. They encode a member of the ATP-
binding cassette (ABC) sub-family 1 transporters, regucalcin and
the Myc proto-oncogene protein, respectively. ABC transporters
have been suggested to mediate drug sensitivity of subpopulations
of cancer stem-like cells across many tumour types [45][46][47].
Regucalcin is a calcium-binding protein involved in calcium
homeostasis and carbohydrate metabolism, and is recently
reported as a newly identified tumour suppressor [48]. It is also
not surprising for the module to include the well-established proto-
oncogene MYC which has a wide spectrum of downstream
effectors [49][50], and the SLC family member SLC13A3, the
expression of which found to be down-regulated in tumour cells
over-expressing MYC family genes [51][52]. Interestingly, MYC
did not appear in the entire set of genes in MCODE modules.
Decreased expression of one of RGN’s coexpression partner
SELENBP1 which encodes a selenium-binding protein, has also
been shown to be associated with multiple tumour types
[53][54][55].
In the unique module identified by DiME from the GBM
glioma network, the RRAS oncogene, the SH3 domain binding
kinase gene SBK1 and the transcription factor SOX8 involved in
CNS development have the highest degrees of connectivity. RRAS
regulates cell migration and has been identified as a glioblastoma
multiforme signature gene [56][57]. SBK1 is dysregulated in
multiple cancer types and may display a broad range of cellular
functions [58]. SOX8 has been shown to be predominantly
expressed in oligodendrocytomas, astrocytomas and glioblastomas
and may be an early glial marker for medulloblastomas [59]. In
Figure 5 this module corresponds to the ‘‘regulation of vesicle-
related processes’’ node as it contains several components involved
in intra-cellular vesicle transport.
In conclusion, DiME algorithm identified two disease modules
missed by the other two algorithms whose components were
established targets of tumour treatment and/or key regulatory
molecules in glioma. Gene members of the above two mentioned
modules are provided in Tables S2 and S3 in File S1.
Discussion
One major advantage of our DiME algorithm is that it is
relatively fast, with worst case time complexity of O(N2). In
general for a network of ,7,000 nodes, it takes less than one
second to fully optimise a single solution on a Core i7 computer
using a single thread. Another advantage of the algorithm is its
small number of parameters and robustness to varying parameters.
The only user-specified parameter is the solution set size, and in
most cases 50,100 solutions should give satisfactory results for
large networks.
Since optimization of individual solutions is independent of one
another, the optimization process is readily parallelizable. In our
implementation the publicly available OpenMPH [60] library for
parallel computing on IntelH processors is used, and multi-core
processor users can specify the number of parallelly processing
cores to be used.
We have not only demonstrated that the new DiME algorithm
outperforms the original Tabu search-based community extraction
method in terms of speed and maxima of ~W values, but also
shown that the original method does not seem to be feasible for
analysing coexpression networks even if it could handle the time
complexity - the modules extracted by the original method were
Figure 7. Heat map showing expression landscape of all genes in the 7 conserved common modules across grade II glioma and
GBM samples. Rows correspond to genes grouped by modules and columns correspond to samples grouped by tumour grade.
doi:10.1371/journal.pone.0086693.g007
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too large for interpretation, and contained unconnected nodes
which are indicative of premature convergence.
An additional advantage of incorporating the B-score scheme
into our DiME algorithm is that a simple hard-thresholding
approach alone is sufficient to retain most of the large modules.
Whereas modules with low statistical significance may be trimmed
into significant ones using the OSLOM algorithm proposed by
Lancichinetti et al. (2011) [17], such a procedure might be
inefficient as the calculation of B-scores is quadratic in time with
respect to module size and may become computationally
expensive, especially for huge modules that arise from modular-
ity-based community detection algorithms.
Note that while more than 45% of extracted genes were
retained under the most stringent B-score cutoff used (1|10{5),
such robustness against statistical significance cutoffs was not
observed for other algorithms such as MCODE and modularity-
based community detection. Even at a less stringent B-score cutoff
of 0:05, the MCODE and modularity-based modules would
generally suffer from a loss of over 50% and 95% of identified
genes, respectively (see Table S1 in File S1 for comparison).
Therefore, we did not include the B-score significance measure for
the MCODE modules in all comparative analyses.
The problem of resolution limit in community detection
methods is also manifested in the size and statistical significance
of modules. Using the Rembrandt grade II glioma data as an
example, the largest module identified by the community detection
method as of [30], consisting of 1,372 genes out of a total of 3,888,
was deemed statistically non-significant under the B-score scheme
(mean B~0:17). A careful inspection of this large module showed
that three of the statistically significant (Bv0:001) DiME modules
(corresponding to immune response, macromolecular complex
transport and localization and nucleobase metabolism and cell
differentiation, see Figures 4 and 5), with sizes of 212, 39 and 42
genes respectively, are contained or almost contained within it (i.e.,
larger than 90% overlap with the large module). It also has
significant overlaps with several other non-significant DiME
modules. In comparison, three MCODE modules are contained
within the above mentioned large module, with sizes of 77, 18 and
13 genes respectively (corresponding to immune responses, nucleic
acid metabolism and regulation of cytoskeleton). Such an
observation suggests that community detection is not appropriate
for disease module identification in large biological networks, since
it generates huge modules with large numbers of genes which add
difficulties to validation and interpretation.
An analysis of the variability of module identification results
show that core modular structure of the Rembrandt coexpression
networks used in the case study is well conserved under varying
network construction parameters (see Appendix, Figure 3). Such
conservation is consistent with the concept of ‘‘module core’’
described by the original authors of module extraction [12]. It is
worth pointing out, however, that the less conserved modules do
not necessarily bear little functional significance in the network, as
their fluctuations may be due to the noise in the biological data
itself, rather than in the module identification algorithm. The
construction of a highly robust network per se is still a highly active
area of research and is not the main focus of this paper.
The module connectivity networks for grade II glioma and
GBM samples provide a high-level yet insightful understanding of
brain tumour progression and the associated rewiring of cellular
machinery. A common expression signature of both tumour
grades is down-regulation of nervous system development and
normal neuronal functions (e.g., synaptic transmission) and up-
regulation of cell cycle (cell proliferation) related progresses
(Figures 4 and 5), light green and red nodes). Such concomitant
alterations in transcriptome are consistent with a malignant
phenotype - cells that are becoming less differentiated and are
proliferating more. The coordination between the two types of
functional processes is remarkably strengthened in GBM com-
pared with grade II glioma samples (manifested in the increased
coexpression links between the corresponding modules), a possible
consequence of the significant increase in the transcription factors
AR and ETS1 shared by the two processes in both grades. Core
components of the two processes are also conserved across
microarrays, as is shown by the expression levels of modules 2,
3, and 6 in Figure 7.
Also of pathological significance is the significant increase in the
activity of the angiogenesis-related module in GBM. The module
is linked via coexpression to another module which is related to
extracellular matrix organisation and controls cell morphology
and physical interaction with its environment, in accordance with
putative functions of extracellar matrix components (e.g., TGF b-
induced, encoded by TGFBI from the extracellular matrix
organisation module) in promoting angiogenesis [61]. The
increase in these modules as well as those representing cell cycle
processes and the further decrease in modules associated with
differentiation are indicative of a tumour that is becoming
markedly more malignant with progression from grade II to
GBM. As this analysis has shown that all of these processes are co-
ordinately regulated, the identification of two transcription factors
that are associated with all or almost all of these modules suggests
that both E2F4 and ETS1 play a significant role in the
pathogenesis of glioma.
Our results suggest that DiME could uncover statistically
significant modules whose highly connected members have been
found to be important biomarkers or key cancer regulators, as
exemplified in the last section in Results. These modules were not
found in the overlap of genes between DiME and MCODE
modules, indicating the inherently different modular structures
detected by the two methods. Though MCODE was able to
identify genes such as TGFB2, a putative glioma tumour regulator
and drug target [62][63], they were mostly included in modules
that displayed very low statistical significance (B-score close to 1),
indicating a high likelihood of statistical artifacts. Because these
individual candidate genes with weaker topological context but
significant dysregulation in cancer are readily identifiable using
single-gene analysis methods such as differential expression and
copy number variation, we conclude that our DiME algorithm can
be applied to biological networks in parallel with single-gene
analysis for enhanced understanding of the overall shift in the
cellular regulatory program in disease.
Taken together, the above discussed modules may be viewed as
potential disease modules whose dynamic activity dictates tumour
progression. The results show that the core methodology
introduced in this paper, including the DiME algorithm and the
accompanying B-score scheme for evaluating statistical signifi-
cance, is capable of extracting modules of coordinately expressed
genes that point to key regulators in disease networks and thus
provide a more systematic understanding of complex disease
progression.
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